Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial

BACKGROUND: This study aimed to investigate the efficacy and safety of subcutaneous injection of peginterferon lambda in patients hospitalized with COVID-19. METHODS: In this study (NCT04343976), patients admitted to hospital with COVID-19 confirmed by RT-PCR from nasopharyngeal swab were randomly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Myung-Ho, Elbaz, Josh, Jilg, Nikolaus, Gustafson, Jenna L., Xu, Min, Hatipoglu, Dilara, Nohelty, Eric, Kim, Arthur Y., Chung, Raymond T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002416/
https://www.ncbi.nlm.nih.gov/pubmed/36910479
http://dx.doi.org/10.3389/fmed.2023.1095828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002416/
https://www.ncbi.nlm.nih.gov/pubmed/36910479
http://dx.doi.org/10.3389/fmed.2023.1095828

Ejemplares similares